Company news
NeuroOne Medical Technologies Corporation news in 2026
NeuroOne Medical Technologies Corporation's news releases, calls and decks from 2026, newest first.
NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System
October 29, 2026
NeuroOne Featured in New York Post on OneRF® Patient’s Remarkable Journey to Overcome Debilitating Facial Pain
October 27, 2026
NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program
October 22, 2026
NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology
October 8, 2026
NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order
October 5, 2026
NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement
September 17, 2026
NeuroOne Medical Technologies Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform
August 27, 2026
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8: 30 a.m. Eastern Time
August 3, 2026
NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform
July 29, 2026
NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians
July 27, 2026
NeuroOne(R) Expands Drug Delivery Program Through Collaboration on Pediatric Brain Cancer Clinical Trial
July 16, 2026
NeuroOne(R) Added to Russell Microcap(R) Index
June 29, 2026
NeuroOne(R) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 25, 2026
NeuroOne(R) Announces Preliminary Inclusion in Russell Microcap(R) Index
June 16, 2026
Amendment to Quarterly Report (Form 10-Q/A)
June 12, 2026
NeuroOne(R) to Present at the Planet MicroCap Las Vegas 2026 Conference Wednesday, June 17, 2026 at 12: 00 p.m. Pacific Time
June 8, 2026
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026
May 28, 2026
NeuroOne(R) Medical Technologies Announces Restatement of Financial Results for Quarter Ending March 31, 2026
May 22, 2026
NeuroOne Reports Fiscal Q2 2026 Financial Results and Provides Corporate Business Update
May 12, 2026
NeuroOne(R) Regains Compliance With Nasdaq Listing Requirement
May 4, 2026
NeuroOne(R) Announces Chief Financial Officer Succession Plan
April 30, 2026
NeuroOne(R) to Report Second Quarter Fiscal Year 2026 Financial Results on Tuesday, May 12 at 8: 30 a.m. Eastern Time
April 27, 2026
NeuroOne(R) Medical Technologies Announces Reverse Stock Split to Regain Nasdaq Compliance
April 13, 2026
NeuroOne(R) Medical Technologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
April 1, 2026
NeuroOne(R) Successfully Completes Limited Market Release of OneRF(R) Trigeminal Nerve Ablation System
March 25, 2026
NeuroOne(R) Announces Publication of Clinical Experience With Its OneRF(R) sEEG-Guided Radiofrequency Ablation Technology
March 17, 2026
NeuroOne(R) to Present at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference March 17, 2026 at 1: 20 p.m. Eastern Time
March 10, 2026
NeuroOne(R) Issues Shareholder Letter and Provides Corporate Update
March 8, 2026
NeuroOne(R) Appoints David Wambeke as Chief Business Officer; Concurrently Completes Insider Purchase of 1 Million Shares
March 3, 2026
NeuroOne(R) to Host Virtual Investor Webinar on Thursday, March 12, 2026 at 11: 30 a.m. Eastern Time
February 26, 2026
NeuroOne Reports Fiscal Q1 2026 Financial Results; Expects Product Revenue of At Least $10.5 Million in Fiscal Year 2026
February 17, 2026
NeuroOne(R) to Report First Quarter Fiscal Year 2026 Financial Results on Tuesday, February 17 at 8: 30 a.m. Eastern Time
February 4, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (August 2026)
Investor deck · 21 slides · August 2026
- Investor Presentation (June 2026)
Investor deck · 20 slides · June 2026